(P-1111) Efficacy of Intra-Articular Administration of Rifaquizinone in Rodent Models of Implant Infection Associated with Staphylococcus aureus

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

William J Weiss, MS

Director
University of North Texas Health Science Center
Fort Worth, Texas, United States

MP

Mark E Pulse, MS

Associate Director
University of North Texas Health Science Center
Fort Worth, Texas, United States
PN

Phung Nguyen, BS

Research Investigator
University of North Texas Health Science Center
Fort Worth, Texas, United States
DV

David Valtierra, Master

HSC College of Pharmacy, University of North Texas
Fort Worth, Texas, United States
KP

Kelly Peterson, PhD

HSC College of Pharmacy, University of North Texas
Fort Worth, Texas, United States
AO

Adaeze Ogbonna, Bachelor

HSC College of Pharmacy, University of North Texas
Fort Worth, Texas, United States
LB

Lane Beeman, Bachelor

HSC College of Pharmacy, University of North Texas
Fort Worth, Texas, United States
TD

Tianyu Dai, PhD

Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
LC

Liaobin Chen, PhD

Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Huan Wang, PhD (she/her/hers)

Director of pharmacology and toxicology
TenNor Therapeutics (Suzhou) Ltd
Suzhou, Jiangsu, China (People's Republic)
Zhenkun Ma, PhD (he/him/his)

CEO
TenNor Therapeutics
Suzhou Industrial Park, Jiangsu, China (People's Republic)